Recode Therapeutics Announces Strategic Investment From The Cystic Fibrosis Foundation To Accelerate Development Of Novel Mrna Therapy
Round Type
Corporate Round
Menlo ParkBiotechnologyHealthcareHealth CareInvestors
Description
ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today that it will receive a strategic investment from the Cystic Fibrosis Foundation (CF Foundation) to develop ReCode’s inhaled mRNA-based therapeutic for people with cystic fibrosis (CF), including those with genotypes that do not respond to approved CFTR modulators.
Quick answer
ReCode Therapeutics raised an undisclosed amount in a Corporate Round round, dated January 10, 2023. Investors: Cystic Fibrosis Foundation. ReCode Therapeutics is based in Menlo Park, California, United States.
- How much did ReCode Therapeutics raise?
- ReCode Therapeutics raised an undisclosed amount in a Corporate Round round on January 10, 2023.
- Who invested in ReCode Therapeutics?
- Cystic Fibrosis Foundation is named as investors in this round.
- What does ReCode Therapeutics do?
- ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics.
- Where is ReCode Therapeutics based and how big is it?
- ReCode Therapeutics is based in Menlo Park, California, United States.
- Who are the decision-makers at ReCode Therapeutics?
- Fundz holds 1 contact at ReCode Therapeutics, including the Head of Clinical Operations | Rare Diseases. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as ReCode Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Azora Therapeutics, Inc. (DE) raised $62K (Pre-Seed) on February 23, 2023.
- ReAlta Life Sciences raised $12M on February 22, 2023.
- U.S. Renal Care raised $3.1M (Seed) on February 16, 2023.
- MOLECULAR WORLD HEALTH raised $5K (Pre-Seed) on February 9, 2023.
- Ostial Corporation raised $7.5M (Series C) on February 8, 2023.
- NeOnc Technologies raised $10M on February 8, 2023.
Who to call at ReCode Therapeutics, and when
A new round usually means ReCode Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ReCode Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ReCode Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ReCode Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ReCode Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ReCode Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.